Abstract
MRI Outcomes from the Long-term Extension Study of Tolebrutinib in Patients with Relapsing Multiple Sclerosis: 2-Year Results (P6-3.012)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have